discovery Teaching and Learning
HARVARD PROGRAM IN THERAPEUTIC SCIENCE
New Science for Better Medicines The Harvard Program in Therapeutic Science (HiTS) and its flagship Laboratory of Systems Pharmacology (LSP) use laboratory-based experiments, computer science and molecular medicine to advance drug discovery and precision medicine. HiTS trains pre- and postdoctoral students to be leaders in drug discovery and builds partnerships with hospitals to test new theories. Directed by Peter Sorger, the Otto Krayer Professor of Systems Pharmacology, the LSP is focusing on the beneficial and adverse effects of cancer drugs and on new ways to developing therapies for complex and incurable diseases such as Alzheimer’s disease. In 2016, HiTS launched its Program in Regulatory Science and established the Henri and Belinda Termeer Early Career Investigator Fellowship jointly with Massachusetts General Hospital. Funded by a $5 million gift from the Termeers, this program supports a home in the LSP for a clinician-scientist and accelerates the application of systems pharmacology concepts to clinical trials and patient care.
